Bal Pharma Limited (BOM:524824)
75.54
+1.22 (1.64%)
At close: Feb 13, 2026
Bal Pharma Revenue
Bal Pharma had revenue of 880.16M INR in the quarter ending December 31, 2025, with 13.55% growth. This brings the company's revenue in the last twelve months to 3.11B, down -3.03% year-over-year. In the fiscal year ending March 31, 2025, Bal Pharma had annual revenue of 3.03B, down -10.65%.
Revenue (ttm)
3.11B
Revenue Growth
-3.03%
P/S Ratio
0.39
Revenue / Employee
3.15M
Employees
986
Market Cap
1.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3.03B | -361.36M | -10.65% |
| Mar 31, 2024 | 3.39B | 350.03M | 11.51% |
| Mar 31, 2023 | 3.04B | 230.02M | 8.18% |
| Mar 31, 2022 | 2.81B | 306.86M | 12.25% |
| Mar 31, 2021 | 2.51B | 794.34M | 46.43% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.57B |
| Parnax Lab | 2.05B |
| Lactose (India) | 1.37B |
| Astonea Labs | 1.17B |
| Aayush Wellness | 1.11B |
| Coral Laboratories | 889.77M |
| Sotac Pharmaceuticals | 846.72M |
| Mercury Laboratories | 761.53M |